TBPH

14.66

2.52% 0.36

Dopo l'orario di chiusura: 14.66

Theravance Biopharma Inc (TBPH)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$14.30

Aprire:

$14.31

Volume 24 ore:

393.27K

Relative Volume:

0.99

Capitalizzazione di mercato:

$738.30M

Reddito:

$62.02M

Utile/perdita netta:

$-45.65M

Rapporto P/E:

-15.93

EPS:

-0.92

Flusso di cassa netto:

$-9.60M

1 W Prestazione:

+2.66%

1M Prestazione:

+0.41%

6M Prestazione:

+50.05%

1 anno Prestazione:

+77.91%

Intervallo 1D:

$14.11

$14.70

Intervallo di 1 settimana:

$13.95

$14.70

Portata 52W:

$7.90

$15.15

Theravance Biopharma Inc Stock (TBPH) Company Profile

Nome

Theravance Biopharma Inc

Settore

Healthcare (1135)

Industria

Biotechnology (635)

Telefono

650-808-6000

Indirizzo

UGLAND HOUSE, SOUTH CHURCH STREET, GEORGE TOWN, GRAND CAYMAN

Dipendente

Cinguettio

Prossima data di guadagno

2024-11-12

Ultimi documenti SEC

TBPH's Discussions on Twitter

Confronta TBPH con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
TBPH Theravance Biopharma Inc	14.66	720.17M	62.02M	-45.65M	-9.60M	-0.92
VRTX Vertex Pharmaceuticals Inc	425.57	107.66B	11.39B	3.64B	3.50B	13.99
REGN Regeneron Pharmaceuticals Inc	651.80	68.74B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	456.04	58.93B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	818.50	50.51B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	189.60	41.29B	447.02M	-1.18B	-868.57M	-6.1812

Theravance Biopharma Inc Stock (TBPH) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-09-12	Iniziato	B. Riley Securities	Buy
2024-08-06	Downgrade	Leerink Partners	Outperform → Market Perform
2024-04-12	Iniziato	BTIG Research	Buy
2024-01-08	Downgrade	Evercore ISI	Outperform → In-line
2022-05-23	Iniziato	SVB Leerink	Outperform
2021-11-05	Aggiornamento	JP Morgan	Underweight → Neutral
2021-09-15	Downgrade	JP Morgan	Overweight → Underweight
2021-08-25	Downgrade	Morgan Stanley	Overweight → Underweight
2021-08-24	Downgrade	Cowen	Outperform → Market Perform
2020-10-14	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2020-07-07	Iniziato	JP Morgan	Overweight
2020-06-15	Iniziato	Morgan Stanley	Equal-Weight
2020-05-13	Iniziato	Cowen	Outperform
2020-01-08	Reiterato	H.C. Wainwright	Buy
2019-11-06	Aggiornamento	Robert W. Baird	Underperform → Neutral
2019-10-29	Iniziato	H.C. Wainwright	Buy
2018-03-29	Ripresa	Piper Jaffray	Overweight
2017-08-17	Iniziato	Evercore ISI	Outperform
2017-06-16	Iniziato	Cantor Fitzgerald	Overweight
2017-05-11	Reiterato	Needham	Buy
2016-12-21	Iniziato	Needham	Buy
2016-11-03	Iniziato	Piper Jaffray	Overweight
2016-10-12	Downgrade	Robert W. Baird	Neutral → Underperform
2016-08-03	Downgrade	BofA/Merrill	Neutral → Underperform
2016-06-20	Iniziato	Guggenheim	Buy
2016-06-20	Reiterato	Leerink Partners	Outperform
2016-05-12	Iniziato	Leerink Partners	Outperform
2016-05-05	Downgrade	BofA/Merrill	Buy → Neutral
2015-02-03	Aggiornamento	Robert W. Baird	Underperform → Neutral

Mostra tutto

Theravance Biopharma Inc Borsa (TBPH) Ultime notizie

03:43 AM

Will a bounce in Theravance Biopharma Inc. offer an exitWeekly Market Outlook & Weekly Chart Analysis and Trade Guides - newser.com

03:43 AM

02:45 AM

What consensus target says about Theravance Biopharma Inc. (0TB) stockJuly 2025 Outlook & Consistent Profit Alerts - newser.com

02:45 AM

12:19 PM

Can Theravance Biopharma Inc. stock maintain operating margins2025 Key Lessons & Low Risk High Win Rate Picks - newser.com

12:19 PM

11:55 AM

Why Theravance Biopharma Inc. stock is in analyst buy zone2025 Support & Resistance & Reliable Breakout Forecasts - newser.com

11:55 AM

11:39 AM

Why Theravance Biopharma Inc. (0TB) stock remains stableJuly 2025 Sentiment & Fast Exit Strategy with Risk Control - newser.com

11:39 AM

05:46 AM

Theravance Biopharma, Inc. (NASDAQ:TBPH) Given Consensus Recommendation of "Buy" by Analysts - MarketBeat

05:46 AM

04:28 AM

Theravance Biopharma Inc. stock trendline breakdownJuly 2025 PostEarnings & Real-Time Buy Zone Alerts - newser.com

04:28 AM

Nov 01, 2025

Can Theravance Biopharma Inc. stock deliver consistent earnings growth2025 Growth vs Value & Daily Volume Surge Trade Alerts - newser.com

Nov 01, 2025

Can Theravance Biopharma Inc. stock attract ESG capital inflowsJuly 2025 Intraday Action & Daily Entry Point Alerts - newser.com

Nov 01, 2025

Can Theravance Biopharma Inc. (0TB) stock sustain revenue momentumOptions Play & Weekly Breakout Watchlists - newser.com

Nov 01, 2025

Why Theravance Biopharma Inc. (0TB) stock benefits from AI revolutionJuly 2025 Institutional & Fast Gain Stock Trading Tips - newser.com

Nov 01, 2025

Is Theravance Biopharma Inc. (0TB) stock a momentum leaderProduct Launch & Free Reliable Trade Execution Plans - newser.com

Nov 01, 2025

Oct 31, 2025

How to escape a deep drawdown in Theravance Biopharma Inc.July 2025 Intraday Action & Capital Efficient Trading Techniques - newser.com

Oct 31, 2025

What to expect from Theravance Biopharma Inc. in the next 30 daysIPO Watch & Weekly Chart Analysis and Trade Guides - newser.com

Oct 31, 2025

Can Theravance Biopharma Inc. (0TB) stock hit consensus price targetsJuly 2025 Recap & AI Powered Buy and Sell Recommendations - newser.com

Oct 31, 2025

Will Theravance Biopharma Inc. stock see insider buyingIPO Watch & Weekly High Return Stock Opportunities - newser.com

Oct 31, 2025

Oct 30, 2025